N/A N=24 Treatment

Extended Depth of Focus Contact Lenses for Presbyopia

Presbyopia

Bottom Line

View on ClinicalTrials.gov: NCT05495971 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2024

Primary outcome: Primary: LogMAR Visual Acuity — -0.07 logMAR

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: NaturalVue Multifocal (Device)
Age: Adult, Older Adult · 45+ yrs
Sex: All
Sponsor: Visioneering Technologies, Inc
Primary completion: May 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY LogMAR Visual Acuity	-0.07	—

Summary

VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.

Eligibility Criteria

Inclusion Criteria

Suitable and able to wear contact lenses
Normal best corrected vision (20/25 or better)
Need reading add +2.00 or stronger

Exclusion Criteria

Pre-existing ocular condition that would contraindicating lens wear

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05495971). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.